Nivolumab-Induced Granulomatous Inflammation of the Pleura

Journal of Thoracic Oncology

Volumn 12, Issue 7, 2017, Pages e100-e101

  Benn, Bryan S ^a   Lombard, Charles M ^b   Krishna, Ganesh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b EL CAMINO HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NIVOLUMAB;

ADULT; ANALYSIS; CASE REPORT; DYSPNEA; GRANULOMATOUS INFLAMMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LYMPHOCYTE; MALE; MEDICAL HISTORY; METASTATIC MELANOMA; MIDDLE AGED; MYASTHENIA GRAVIS; PLEURA BIOPSY; PLEURA EFFUSION; PLEURAL FLUID ANALYSIS; PLEURISY; POSITRON EMISSION TOMOGRAPHY-COMPUTED TOMOGRAPHY; PRIORITY JOURNAL; RECURRENT DISEASE; SARCOIDOSIS LIKE GRANULOMATOUS REACTION; THORACOCENTESIS; THORACOSCOPY; CHEMICALLY INDUCED; INFLAMMATION; PATHOLOGY; PLEURA;

HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NIVOLUMAB; PLEURA;

EID: 85020929887     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2017.03.006     Document Type: Letter

References (9)

1. Robert, C., Long, G.V., Brady, B., et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372 (2015), 320–330.
2. Borghaei, H., Paz-Ares, L., Horn, L., et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med 373 (2015), 1627–1639.
3. Brahmer, J., Reckamp, K.L., Baas, P., et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373 (2015), 123–135.
4. Abdel-Wahab, N., Shah, M., Suarez-Almazor, M.E., Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports. PLoS One, 11, 2016, e0160221.
5. Koelzer, V.H., Rothschild, S.I., Zihler, D., et al. Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study. J Immunother Cancer, 4, 2016, 13.
6. Danlos, F.X., Pagès, C., Baroudjian, B., et al. Nivolumab-induced sarcoid-like granulomatous reaction in a patient with advanced melanoma. Chest 149 (2016), e133–e136.
7. Montaudié H, Pradelli J, Passeron T, Lacour JP, Leroy S. Pulmonary sarcoid-like granulomatosis induced by nivolumab [e-pub ahead of print]. Br J Dermatol. http://dx.doi.org/10.1111/bjd.14808, accessed January 3, 2017.
8. Suozzi, K.C., Stahl, M., Ko, C.J., et al. Immune-related sarcoidosis observed in combination ipilimumab and nivolumab therapy. JAAD Case Rep 2 (2016), 264–268.
9. Kim, C., Gao, J., Shannon, V.R., Siefker-Radtke, A., Systemic sarcoidosis first manifesting in a tattoo in the setting of immune checkpoint inhibition. BMJ Case Rep, 2016, 2016 bcr2016216217.